Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cliniqa™ Liquid QC™ CoV-2 IgG Control

A quality control for use with qualitative assays for Covid-19 IgG antibodies to the SARS-CoV-2 spike (S) protein.

Supplier:  Cliniqa™ 91494

Catalog No. 22-100-115


Explore all special offers
Add to Cart

Alert:

Human-sourced material. Treat as potentially infectious.

This item is not returnable. View return policy

Description

Description

Clinqa™ Liquid QC™ CoV-2 IgG Control Kit is a liquid stable, ready to use bi-level control for use with assays designed to produce qualitative results for Covid-19 IgG antibodies to the SARS-CoV-2 spike (S) protein. Intended for in vitro diagnostic use.

The Liquid QC™ CoV-2 IgG Control kit provides two distinct levels. Each kit includes six 3 mL filled vials per level. All laboratories should establish their own expected ranges and tolerance limits based on their test system.

Compatible with the following instruments and assays:

  • Ortho Vitros™ Anti-SARS-CoV-2 IgG Test
  • Beckman Coulter Access™ SARS-CoV-2 IgG Antibody Test
  • Siemens™ SARS -CoV-2 Total Antibody Test
  • Biomerieux™ VIDAS™ anti-SARS-CoV-2 IgG Test
Specifications

Specifications

IgG
Ortho Vitros™, Beckman Coulter Access™, Siemens Dimension™, Biomerieux™ Vidas™ Antibody Tests
Vials
30 Days at 2°C to 8°C
Control
Whole Blood, Serum, Plasma
12 Vials
Liquid
Videos
Safety and Handling

Safety and Handling

ShelfLife : 2 Years

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.